Jeffrey Skolnik

Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design

Jeffrey Skolnik, Jeffrey S. Barrett, Bhuvana Jayaraman et al. · Journal of Clinical Oncology · 2008 · 261 citations · Full text

Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma

Roberto Chiarle, Leo M. Budel, Jeffrey Skolnik et al. · Blood · 2000 · 218 citations

Antitumor Activity in <i>RAS</i> -Driven Tumors by Blocking AKT and MEK

Anthony W. Tolcher, Khurum Khan, Michael Ong et al. · Clinical Cancer Research · 2014 · 135 citations · Full text

S-Phase Kinase-Associated Protein 2 Expression in Non-Hodgkin's Lymphoma Inversely Correlates with p27 Expression and Defines Cells in S Phase

Roberto Chiarle, Yan Fan, Roberto Piva et al. · American Journal Of Pathology · 2002 · 110 citations · Full text

Cancer Research, Lymphoid Neoplasia, Cell Regulation +11

Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer

Gilles Vassal, Raphaël F. Rousseau, P. Blanc et al. · European Journal of Cancer · 2014 · 93 citations · Full text

Cancer Management, Cancer Education, Gynecology Oncology +24